x

Search for a clinical trial

* (*) mandatory field

A Phase 3 Efficacy and Safety Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy - ES (Completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Ptc therapeutics, inc.
  • Website
    • Phase : III
  • Principal investigator of clinical trial

  • Dr Jaume COLOMER OFERIL
  • Servicio de Neurología
  • Hospital Sant Joan de Déu Barcelona
  • Paseo de Sant Joan de Déu, 2
  • 08950 ESPLUGUES DE LLOBREGAT
  • SPAIN
  • More information
  • Phone  : 34 93 253 21 00
  • Fax  : -
  • Website
Last update: February 2017

Part of a multinational clinical trial

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.